HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells

Archive ouverte

Planchais, Cyril | Kök, Ayrin | Kanyavuz, Alexia | Lorin, Valérie | Bruel, Timothée | Guivel-Benhassine, Florence | Rollenske, Tim | Prigent, Julie | Hieu, Thierry | Prazuck, Thierry | Lefrou, Laurent | Wardemann, Hedda | Schwartz, Olivier | Dimitrov, Jordan | Hocqueloux, Laurent | Mouquet, Hugo

Edité par CCSD ; Elsevier Inc -

International audience. Mucosal immune responses to HIV-1 involve the recognition of the viral envelope glycoprotein (gp)160 by tissue-resident B cells and subsequent secretion of antibodies. To characterize the B cells “sensing” HIV-1 in the gut of infected individuals, we probed monoclonal antibodies produced from single intestinal B cells binding to recombinant gp140 trimers. A large fraction of mucosal B cell antibodies were polyreactive and showed only low affinity to HIV-1 envelope glycoproteins, particularly the gp41 moiety. A few high-affinity gp140 antibodies were isolated but lacked neutralizing, potent ADCC, and transcytosis-blocking capacities. Instead, they displayed cross-reactivity with defined self-antigens. Specifically, intestinal HIV-1 gp41 antibodies targeting the heptad repeat 2 region (HR2) cluster II cross-reacted with the p38α mitogen-activated protein kinase 14 (MAPK14). Hence, physiologic polyreactivity of intestinal B cells and molecular mimicry-based self-reactivity of HIV-1 antibodies are two independent phenomena, possibly diverting and/or impairing mucosal humoral immunity to HIV-1.

Suggestions

Du même auteur

Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity

Archive ouverte | Prigent, Julie | CCSD

International audience. Human high-affinity antibodies to pathogens often recognize unrelated ligands. The molecular origin and the role of this polyreactivity are largely unknown. Here, we report that HIV-1 broadly...

HIV-1 treatment timing shapes the human intestinal memory B-cell repertoire to commensal bacteria

Archive ouverte | Planchais, Cyril | CCSD

International audience. Abstract HIV-1 infection causes severe alterations of gut mucosa, microbiota and immune system, which can be curbed by early antiretroviral therapy. Here, we investigate how treatment timing ...

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

Archive ouverte | Planas, Delphine | CCSD

International audience. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.7 and B.1.351 variants were first identified in the United Kingdom and South Africa, respectively, and have since spread to ...

Chargement des enrichissements...